As anticipated, ARHGDIA expression inversely correlated with its targeting miRs, miR-346 and miR-361-3p, in the TCGA-PRAD data set (Fig. S16a, b). The gene discussed is ARHGDIA; the disease is prostate adenocarcinoma.